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Physico Chimique, Paris, France; and §Department of Mathematics and Physics, Shanghai University of Electric Power, Shanghai, ChinaABSTRACT Alzheimer’s disease is associated with the abnormal self-assembly of the amyloid-b (Ab) peptide into toxic b-rich
aggregates. Experimental studies have shown that hydrophobic nanoparticles retard Ab fibrillation by slowing down the nucle-
ation process; however, the effects of nanoparticles on Ab oligomeric structures remain elusive. In this study, we investigate the
conformations of Ab(16-22) octamers in the absence and presence of a single-walled carbon nanotube (SWCNT) by performing
extensive all-atom replica exchange molecular-dynamics simulations in explicit solvent. Our simulations starting from eight
random chains demonstrate that the addition of SWCNT into Ab(16-22) solution prevents b-sheet formation. Simulation starting
from a prefibrillar b-sheet octamer shows that SWCNT destabilizes the b-sheet structure. A detailed analysis of the Ab(16-22)/
SWCNT/water interactions reveals that both the inhibition of b-sheet formation and the destabilization of prefibrillar b-sheets by
SWCNT result from the same physical forces: hydrophobic and p-stacking interactions (with the latter playing a more important
role). By analyzing the stacking patterns between the Phe aromatic rings and the SWCNT carbon rings, we find that short ring–
centroid distances mostly favor parallel orientation, whereas large distances allow all other orientations to be populated. Overall,
our computational study provides evidence that SWCNT is likely to inhibit Ab(16-22) and full-length Ab fibrillation.INTRODUCTIONAlzheimer’s disease (AD) is characterized by amyloid
deposits predominantly composed of the 40- to 42-residue-
long amyloid-b peptides (Ab40/Ab42) (1). X-ray diffraction
data show that these deposits consist of fibrils that display
a cross-b structure with the b-strands perpendicular and the
interstrand hydrogen bonds (H-bonds) parallel to the fibril
axis (2). In vitro fibrillation of Ab is described by a nucle-
ation-elongation process characterized by a lag phase
associated with the formation of a critical nucleus, after
which fibril growth proceeds rapidly (3). Before nucleation
occurs, Ab can form a variety of metastable intermediate
oligomeric states with different association numbers and
structures, such as small oligomers, Ab-derived diffusible
ligands (ADDLs), and protofibrils with increasing b-sheet
structure (4,5).
Although the molecular mechanism of AD pathogenesis
remains elusive, there is increasing experimental evidence
that the key pathological species are transient b-rich oligo-
mers, which therefore represent therapeutic targets for
treatment of AD (5,6). The goal of preventing Ab b-sheet
formation by means of peptide-based inhibitors (7), small
molecules (8), or proteins (9) has been pursued for many
years and is still a very active field of research. However,
investigators have not yet been able to use the proteins
designed in these studies to construct therapeutic agents
against AD, in part because of the problem of blood-brain
barrier permeability (10). Recently, a new class of agentsSubmitted June 11, 2011, and accepted for publication September 29, 2011.
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0006-3495/11/11/2267/10 $2.00emerged from the observation that the binding of proteins
to nanoparticle surfaces affects protein folding and aggre-
gation (11,12). Experimental studies indicate that fullerene
(13), carbon nanotubes (14,15), and polymeric (16) and
fluorinated nanoparticles (17) inhibit/promote amyloid
formation depending on their surface physicochemical
properties by increasing/decreasing the lag phase time for
nucleation, but they all leave the elongation phase
invariant, suggesting a surface-modulated nucleation mech-
anism (15,16). There is strong evidence that the protein’s
intrinsic stability also affects the surface-mediated nucle-
ation process. For example, Linse et al. (15) demonstrated
that hydrophobic (HP) copolymeric NiPAM:BAM nanopar-
ticles accelerate the fibrillation of the b2-microglobulin
protein, which is b-sheet-rich in its native form, whereas
they retard the fibrillation of Ab40 (16), an intrinsically
disordered peptide. Based on fibrillation kinetics experi-
ments, Linse et al. suggested that binding of monomeric
Ab40 and prefibrillar oligomers to the nanoparticle
surfaces prevents fibrillation. Despite these observations,
however, details about the Abnanoparticle interaction
and the structures of the oligomeric species prenucleation
remain to be determined. Such knowledge is important
for elucidating the effects of HP nanoparticles on Ab
aggregation.
Single-walled carbon nanotubes (SWCNTs) are HP,
tubular nanostructures with diameters of only 0.4–3.5 nm.
They can easily enter into the cytoplasm and nucleus through
the lipid bilayer (18,19). No short-term (20) or long-term
(21) cytotoxicity of SWCNTs has been reported. These
contradictory toxic effects clearly need to be clarified anddoi: 10.1016/j.bpj.2011.09.046
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FIGURE 1 Calculated secondary structure probability of each residue in
the REMD runs for random-Ab(16-22) and random-Ab(16-22)þSWCNT
at 310 K for (C) b-sheet, (D) coil, (E) bend, and (F) b-bridge. The initial
random states for the two runs are given in panels A and B. Two different
views of the initial state for the random-Ab(16-22)þSWCNT run are shown
in B.
2268 Li et al.understood. As a first step toward understanding the effects
of HP nanoparticles on the low-molecular-weight aggre-
gates of Ab, we studied an SWCNT and an octamer of the
16-22 fragment of Ab, Ab(16-22) as a model system. Our
choice of an octamer was motivated by recent all-atom
molecular-dynamics (MD) studies indicating that the
minimum nucleus size consists of at least eight Ab(16-22)
peptides based on the stability of preformed b-sheet assem-
blies (22,23). Our choice of the Ab(16-22) peptide was
based on the following factors: First, computational deter-
mination of all-atom Ab monomeric equilibrium structures
is feasible in explicit solvent (24), but one is faced with
a convergence issue for all-atom dimers to pentamers
(25,26). In contrast, the length of Ab(16-22) (seven amino
acids) enables the computational study of all-atom octamers
at equilibrium in the presence of an SWCNT in explicit
solvent. Second, Ab(16-22) peptide, which includes the
central HP core, CHC (LVFFA), is recognized as being
essential for Ab fibrillation (27,28) and also forms amyloid
fibrils with antiparallel b-strands in isolation (29). Third, the
KLVFF motif is a primary target in the search for aggrega-
tion inhibitors for AD therapeutics (30,31). Finally, investi-
gators have examined the dynamics and thermodynamics of
Ab(16-22) oligomerization without nanoparticles using
coarse-grained (CG, up to 8-mer) (32,33) and all-atom (up
to 6-mer) simulations (34–36) starting from random confor-
mations or preformed b-sheets, thus providing structural
information for comparison.
Although recent computational studies have focused on
the aggregation of amyloid peptides in the presence of nano-
particles using a CG nanoparticle model (37) or implicit/
explicit lipid models (38–40), to our knowledge, this is the
first computational study to investigate the structures, ther-
modynamics, and interactions of eight Ab(16-22) chains
with an SWCNT using all-atom replica exchange MD simu-
lations (REMD) in explicit solvent. We performed a total of
three independent REMD simulations starting from an
amorphous Ab(16-22) octamer with/without SWCNT and
a prefibrillar b-sheet octamer with SWCNT.MATERIALS AND METHODS
The Ab(16-22) peptide consists of seven residues (Ac-KLVFFAE-NH2)
blocked by acetyl and amine groups as determined experimentally (29).
To mimic the experimental neutral pH condition, the side chains of Lys
and Glu are charged (Lysþ and Glu). Three REMD runs were performed
on three different systems: random-Ab(16-22), random-Ab(16-22)þ
SWCNT, and sheet-Ab(16-22)þSWCNT. Each systemwas placed in a rect-
angular box of SPC water molecules (41) with a minimum distance to the
water box wall of 0.9 nm. The total numbers of atoms for the three systems
are 19,717, 19,663, and 18,682, respectively.Random-Ab(16-22)
The starting state of the Ab(16-22) octamer with random character for each
chain, shown in Fig. 1 A, is the final conformation generated in a 14-ns MD
simulation at 420 K in water starting from fully extended peptides.Biophysical Journal 101(9) 2267–2276Random-Ab(16-22)DSWCNT complex
The initial state of the Ab(16-22) octamer in the complex is the same as in
the Ab(16-22) system. An SWCNTwith a diameter of 0.542 nm is placed at
the center of eight peptide chains. Its length is set to 4.25 nm to provide
a sufficient surface for the Ab(16-22) peptides to adsorb.Sheet-Ab(16-22)DSWCNT complex
This Ab(16-22) b-sheet bilayer is taken from cluster 8 in Fig. 2 A and an
SWCNT is placed between the two sheets (see Fig. 5 A). The SWCNT is
the same size as the one in the random-Ab(16-22)þSWCNT complex.REMD simulations
The REMD simulations are performed with the use of the GROMACS soft-
ware package (42). In accordance with several computational studies of
Ab(16-22) (43–45), the GROMOS96 43A1 force field (46) is used to
describe intra- and intermolecular interactions. To avoid high-pressure arti-
facts at elevated temperature, and following the work of Seibert et al. (47),
we carry out our REMD simulations in the NPTensemble using 40 replicas,
each of 110 ns duration, at temperatures exponentially spaced between
310 K and 420 K. The swap time between two neighboring replicas is
1 ps, which is large compared with the integrated autocorrelation time
of the potential energy of the system at the lowest temperature 310 K
(0.51 ps) (48,49) (see the Supporting Material). The acceptance ratio is
~17% (Fig. S1). To maintain the temperatures at the chosen values, velocity
rescaling coupling method (50) is used with a coupling constant of 0.1 ps.
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FIGURE 2 Structure analysis and FEL of
Ab(16-22) octamers in aqueous solution without
SWCNT at 310 K. (A) Representative structures
for the first eight most-populated clusters. (B)
FEL (in kcal/mol) versus RMSD1 (Ca-RMSD rela-
tive to the b-barrel; cluster 2), and RMSD2 (Ca-
RMSD relative to the parallel b-sheet bilayer;
cluster 8).
SWCNT Inhibits Ab16-22 b-Sheet Formation 2269The pressure is kept at 1 bar with a coupling constant of 1 ps via Berend-
sen’s method (51). Constraints are applied for bond lengths using the
SETTLE algorithm (52) for water, and the LINCS algorithm (53) for
the peptides and SWCNT. This allows an integration time step of 2 fs.
The cutoff for van der Waals interactions is 1.4 nm. A reaction-field correc-
tion (with a cutoff of 1.4 nm) with dielectric permittivity ε ¼ 78 is used for
the long-range electrostatic interactions. The carbon atoms of SWCNT are
uncharged in accordance with Hummer et al. (54), and the Lennard-Jones
parameters for the peptide-SWCNT and water-SWCNT interactions are
obtained using the Lorentz-Berthelot rule.Analysis
We perform the analysis using our in-house-developed codes and the
GROMACS facilities. We discard the first 30 ns of each REMD to remove
the bias of the initial states, except when mentioned otherwise. The struc-
tural properties of each system are therefore based on a total of 3.2 ms.
We analyze the REMD trajectories using several parameters, including
the secondary structure content (via the DSSP program) (55), the free-
energy landscape (FEL), the percentage of various sizes of b-sheet, the
connectivity length (CL), and the probability density function (PDF) of
the angle between two neighboring strands in each b-sheet. A detailed
description of these parameters is given in the Supporting Material.
The Ab(16-22) octameric structures are clustered according to the
method of Daura et al. (56) with a Ca root mean-square deviation (RMSD)
cutoff of 0.3 nm using residues L17-A21, with K16 and E22 excluded
because of their high flexibilities. We calculate all of the Ca-RMSDs by
neglecting the chain identifier of each peptide (see the Supporting Material
for the procedure used to calculate the chain-independent RMSD).
Finally, we probe the Ab(16-22)SWCNT interactions in detail by deter-
mining the probability distribution of the minimum distance between the
side chain of each residue and the SWCNT surface. We also analyze the
p-stacking interactions between the peptides and the nanotube surface by
calculating the PDF of the distance between the centroids of the Phe
aromatic ring and its closest SWCNT carbon ring, and the PDF of the angle
between the two rings. We calculate the interplanar angle by determining
the angle between the surface normals of the two rings. All representations
of the studied systems are drawn with the use of the VMD program (57).RESULTS
Before characterizing the 3D structures and the energy land-
scapes of the Ab(16-22) peptides with and without SWCNT
at 310 K starting from an amorphous, random coil octamer,
we verify the convergence of the two REMD simulations.
To that end, we compare the probability distributions of
end-to-end distance of all chains in a random-Ab(16-22)
(Fig. S2 A) or random-Ab(16-22)þSWCNT (Fig. S2 B)system using the 30–70 ns and 70–110 ns data. As can be
seen in the figures, the distributions overlap very well
when the two independent time intervals are used. It should
be noted that the shapes of the probability distributions of
the end-to-end distance in the two systems look similar,
with a small difference between the full widths at half-
maximum (FWHMs) and heights of the peak. The FWHMs
and heights of the peaks are (0.23 nm, 12%) and (0.30 nm,
19%) without and with SWCNT, respectively. These data
indicate that the peptideSWCNT interactions slightly
influence the global dimension of each chain for such a short
peptide as Ab(16-22). We also calculate the b-sheet contents
using the 30–70 ns and 70–110 ns data. The calculated
b-sheet probabilities within the two time intervals are
42.1% and 47.0% for Ab(16-22) without SWCNT versus
7.8% and 8.1% with SWCNT. Overall, the differences in
b-sheet content and end-to-end distance distribution within
the two time intervals are<5% in magnitude, indicating that
our REMD simulations for the two systems have reasonably
converged.The presence of SWCNT significantly reduces
b-sheet content
We calculate the secondary structure (b-sheet, coil, bend,
b-bridge, and a-helix) probability of each residue at 310 K.
From Fig. 1, C–F, one can see that the secondary structure
content of each residue is strongly affected by SWCNT.
Note that the helix content is negligible in both simulations
(data not shown). The CHC region spanning L17–A21 has
39–75% probabilities to adopt b-sheet states (Fig. 1 C) in
the Ab(16-22) system, with the highest probability of 75%
for V18 and F19, versus 8–15% in Ab(16-22)þSWCNT
complex. Alternatively, the coil percentage for CHC is
much lower with SWCNT (18–55%) than without SWCNT
(75–90%). The b-bridge percentage of the residues V18-
F19-F20 is roughly the same (8%) in both systems (Fig. 1
E), and the residues V18-F19-F20 have similar bend signals
(5% with SWCNT versus 9% without SWCNT (Fig. 1 F).
Averaged over all conformations within 30–110 ns, the
numbers of backbone H-bonds are 30 and 10 in the
random-Ab(16-22) and random-Ab(16-22)þSWCNTBiophysical Journal 101(9) 2267–2276
2270 Li et al.systems, respectively. Taken together, these results demon-
strate that the presence of SWCNT significantly prevents
b-sheet formation of Ab(16-22) peptides.Ab(16-22) peptides form various b-sheet-rich
octamers without SWCNT, and the presence
of SWCNT shifts equilibrium toward random
coil aggregates
To investigate the atomic structures of the peptides in the
absence/presence of SWCNT, we perform a chain-indepen-
dent RMSD-based cluster analysis using a total of 40,000
conformations for each replica. Using a Ca-RMSD of
0.3 nm, we separate the octamers in random-Ab(16-22)
and random-Ab(16-22)þSWCNT systems at 310 K (replica
1) into 166 and 136 clusters, respectively. The large number
of clusters reflects the very high structural heterogeneity of
the Ab(16-22) octamers at physiological temperature. As
expected, the number of clusters increases with temperature
(Fig. S3) and becomes >1000 for T R 391.57 K (replica
index R 30). The centers of the first eight most-populated
clusters of Ab(16-22) octamers, and their populations with
and without SWCNT at 310 K are respectively shown in
Figs. 2 A and 3 A. These clusters represent 43.0% and
39.4% of all conformations in the absence and presence of
SWCNT, respectively.
Without SWCNT, the clusters in Fig. 2 A display various
b-sheet-rich conformations. The first cluster consists of
disordered b-sheet-rich aggregates. The second and fifth
clusters contain five- to eight-stranded b-barrels with mixed
parallel/antiparallel strands. The third, sixth, and eighth
clusters contain parallel b-sheet bilayers consisting of 4þ3
and 4þ4 b-sheet sizes. Finally, the fourth and seventh clus-
ters display two orthogonal b-sheets. The parallel and the
orthogonal b-sheet bilayers have populations of 13.0%
(6.6%þ 3.7%þ 2.7%) and 7.6% (4%þ 3.6%), respectively.Cluster-1
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Biophysical Journal 101(9) 2267–2276In the presence of SWCNT, as shown in Fig. 3 A, the
Ab(16-22) aggregates are fully amorphous, with clusters 1
and 4 being free of any b-sheet, and clusters 2, 3, 5, and
6–8 having two-stranded b-sheets. Aggregates containing
three-stranded b-sheets (Fig. 3 B) are very rare (with a pop-
ulation of 0.3%), and aggregates containing four-stranded
b-sheets are negligible (<0.01%). Overall, in contrast to
the peptides in aqueous solution without SWCNT, none of
the aggregates display parallel b-sheet bilayer, orthogonal
b-sheet bilayer, or b-barrel structures.
Figs. 2 B and 3 C show the FELs of the peptides in
Ab(16-22) and Ab(16-22)þSWCNT systems, respectively,
as a function of RMSD1 and RMSD2. RMSD1 and
RMSD2 are theCa-RMSDs of all conformationswith respect
to the b-barrel (cluster 2) and parallel b-sheet bilayer (cluster
8) shown in Fig. 2 A, respectively, which deviate from each
other by a Ca-RMSD of 0.7 nm. The locations of the first
eight clusters are labeled on each free-energy surface. In
the case of Ab(16-22) in solution, these clusters are delocal-
ized on three basins (Fig. 2 B), whereas in the presence of
SWCNT, all clusters belong to one attraction basin (Fig. 3C).
The differences in the Ab(16-22) aggregates are further
probed by the probability of the b-sheet sizes at 310 K
(Fig. S4 A). We find that without SWCNT, the two- and
three-stranded b-sheets have relatively high probabilities
(20.6% and 13.6%), followed by four-stranded b-sheets
(10.5%). With SWCNT, the population decreases rapidly
with b-sheet size: two-stranded (6.7%), three-stranded
(0.3%), and four-stranded (negligible, <0.01%). Differ-
ences are more pronounced for larger sizes of b-sheets.
The probabilities of five-, six-, seven-, and eight-stranded
b-sheets are respectively 3.2%, 2.5%, 1.1%, and 1.4%
without SWCNT, whereas they vanish in the presence of
SWCNT. A structural inspection shows that these five- to
eight-stranded b-sheets consist of open or closed b-barrels
as well as b-sheet bilayers. (nm)
FIGURE 3 Structure analysis and FEL of
Ab(16-22) octamers with SWCNT at 310 K. (A)
Representative structures for the first eight most-
populated clusters. (B) Representative structures
containing the largest b-sheet (i.e., a three-stranded
sheet). (C) FEL (in kcal/mol) versus RMSD1 (Ca-
RMSD relative to the b-barrel; cluster 2 in Fig. 2 A)
and RMSD2 (Ca-RMSD relative to the parallel
b-sheet bilayer; cluster 8 in Fig. 2 A).
SWCNT Inhibits Ab16-22 b-Sheet Formation 2271Finally, to explore the orientation preference of the
strands in different sizes of b-sheets, we plot the PDF of
the angle between two neighboring strands in a sheet as
a function of b-sheet size (Fig. S4 B). Without SWCNT,
the strands are predominantly antiparallel in a two-stranded
b-sheet, in good agreement with previous computational
studies (34,35). For sheet sizes of 3 and 4, the ratio of anti-
parallel to parallel strand alignment decreases, but the anti-
parallel alignment is still preferred. When the sheet size
increases toR5, the probabilities of antiparallel and parallel
alignments become similar. In the presence of SWCNT, the
antiparallel orientation is more populated for sheet sizes of 2
and 3.DISCUSSION
We performed two 110-ns all-atom REMD simulations in
explicit solvent starting from Ab(16-22) octamer with
random character for each chain without and with SWCNT.
Without SWCNT, our simulation shows that the Ab(16-22)
octamer has an average b-sheet content of 44.5% and
mainly visits disordered b-rich states and, to a lesser extent,
structures with cross-b and b-barrel characteristics. The
structure of the b-barrel is not unique, and the barrel
topology includes five- to eight-stranded b-barrel-like struc-
tures. We expect that the probabilities of the ordered b-rich
structures might be lower using the OPLS force field, and
this remains clearly to be determined on the Ab(16-22) oc-
tamer. A previous computational study on two peptides
showed that GROMOS96 overestimates the stability of the
b conformation, and OPLS generates a better balance
between a-helical and b-sheet structures (58). A recent
REMD study on Ab(16-22) dimer and trimer showed that
GROMOS96 favors b-sheet structures, and OPLS predicts
diverse structures (59).
We also observed these cross-b structures and amorphous
aggregates in our recent CG MD study of the Ab(16-22) oc-
tamer with the two termini of the peptide chain unblocked
(36). The formation of a b-barrel-like structure was also re-
vealed in previous computational studies on Ab(16-22) (33),
KFFE (60), b2m(83-89) (the 83-89 fragment of b2-micro-
globulin) (61) in implicit solvent and generic sequences
(62), and b2m(83-89) in explicit solvent (63).
In the presence of SWCNT, our extensive REMD simula-
tion starting from the same random Ab(16-22) state shows
that the peptides adopt mostly disordered coil states, with
an average b-sheet content of 7.9%. The parallel and orthog-
onal b-sheet bilayers are not populated. This result demon-
strates that SWCNT strongly inhibits Ab(16-22) b-sheet
formation, which consequently would significantly increase
the lag phase time for nucleation. Our result is fully consis-
tent with recent experimental studies conducted by Caba-
leiro-Lago et al. (16), who reported that HP copolymeric
NiPAM:BAM nanoparticles retard Ab40 fibrillation by
slowing down the nucleation process. In the same study,they showed that fibrillation of Ab40 can be reversed by
the addition of NiPAM:BAM nanoparticles up to a particular
time point before mature fibrils appear. To determine
whether SWCNT can destabilize prefibrillar Ab(16-22) b-
sheets, we performed a third REMD run on the sheet-
Ab(16-22)þSWCNT system.SWCNT destabilizes ordered prefibrillar b-sheets
and induces the formation of disordered coil
aggregates
The results of the thirdREMDrun at 310Kare given in Fig. 4.
We first monitor the b-sheet probability of each residue at
four time intervals: 0–20 ns, 20–50 ns, 50–80 ns, and 80–
110 ns (Fig. 4 B). The b-sheet contents of the residues L17-
V18-F19-F20 significantly decrease with simulation time,
reducing to 38%, 46%, 46%, and 28% from their initial
values of 67%, 86%, 84%, and 45%, respectively. The
average b-sheet content within 0–20 ns is 60.3%, and it drops
to 31.5% within an 80–110 ns time period.
The SWCNT-induced destabilization of b-sheet bilayer is
illustrated by the time evolution of the CL at 310 K (Fig. 4
D). For comparison, the time evolution of CL in the random-
Ab(16-22)þSWCNT system at 310 K is also given. The CL
of the Ab(16-22) octamer in the sheet-Ab(16-22)þSWCNT
system increases from its initial value of 5.2 to 6.7 in the last
30 ns of the simulation. Although the CL and the b-sheet
content in sheet-Ab(16-22)þSWCNT system do not reach
the same values of 7.7 and 7.9% as in the random-Ab(16-
22)þSWCNT system within the 110-ns REMD run, their
time evolutions reflect a dissociation of prefibrillar b-sheet
structure by SWCNT and a propensity for random coil
aggregates. We also reveal these features by performing
a cluster analysis for 20,000 conformations generated within
70–110 ns using a Ca-RMSD of 0.3 nm. The centers of the
first five most-populated clusters, representing 38.3% of all
conformations, are shown in Fig. 4 C. It should be noted that
the initial b-sheet bilayer structure, which becomes the 17th
cluster, represents only 2.0% of the 20,000 conformations.
The orthogonal b-sheet bilayer is not populated. Although
the first four clusters are b-rich octamers, two to four of
the eight chains are in random state. Moreover, all of the
chains in cluster 5 are in a coil state. Of interest, a five-
stranded open b-barrel wrapping around SWCNT is
observed in cluster 4. The total population of five-, six-,
seven-, and eight-stranded barrels is 2.1%, implying that
barrel topologies are likely metastable states of Ab(16-22)
oligomers in the presence of SWCNT. Of note, we also
observed an SWCNT-induced b-barrel formation starting
from a preformed b-sheet bilayer in our recent all-atom
MD study of Ab(25-35) peptide (64).
Overall, although our simulation starting from an Ab(16-
22) b-sheet bilayer is not fully converged, it demonstrates
that the presence of SWCNT destabilizes b-sheet structures
and induces the formation of disordered coil aggregates asBiophysical Journal 101(9) 2267–2276
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FIGURE 4 Structural analysis of Ab(16-22)
octamers generated in the 310 K REMD trajectory
starting from a prefibrillar b-sheet octamer (cluster
8 in Fig. 2 A) with an SWCNT placed between the
two b-sheets. (A) Two different views of the initial
state, where b is the perpendicular view of a.
(B) b-sheet content of each residue within four
time intervals: 0–20 ns, 20–50 ns, 50–80 ns, and
80–110 ns. (C) Representative structures for the
first five most-populated clusters. (D) Time evolu-
tion of the CL of the Ab(16-22) octamer in the
sheet-Ab(16-22)þSWCNT system. For compar-
ison, the time evolution of the CL in the random-
Ab(16-22)þSWCNT system is also given. The
number of CLs is averaged every 5 ns.
2272 Li et al.well as metastable b-barrel-like structures. This result indi-
cates that the fibrillation of Ab16-22 can be reversed at its
early stage by the addition of SWCNT. Given that REMD
simulations accelerate the sampling of MD simulations by
an order of magnitude (47), our results indicate that full
destabilization of the Ab(16-22) b-sheet octamer by
SWCNT is a slow process, taking >1.1 ms.SWCNT inhibits Ab(16-22) b-sheet formation
through both HP and p-stacking interactions
To understand the physical driving forces underlying the
b-sheet inhibition and destabilization by SWCNT, we plot
in Fig. 5 the probability distribution of the minimum dis-A
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Biophysical Journal 101(9) 2267–2276tance between the side chain of each residue and SWCNT
surface in the two REMD runs at 310 K (Fig. 5, A and B).
Two probability peaks are seen for each residue, with a domi-
nant peak centered at 0.35 nm for the HP residues L17-V18-
F19-F20-A21. The probabilities of these HP residues at
0.35 nm are all greater than those of K16 and E22. In partic-
ular, the aromatic residues F19 and F20 have the highest
probability at 0.35 nm. These data indicate that the HP resi-
dues L17–A21 have stronger interactions with SWCNT than
the hydrophilic residues K16 and E22, and, remarkably, the
interaction between the two aromatic residues (F19 and F20)
and SWCNT is the strongest in both systems. Our results are
consistent with electron microscope images showing that
peptides containing aromatic rings have strong affinity withum distance (nm)
um distance (nm)
FIGURE 5 Probability distribution of the mini-
mum distance between the side chain of each
residue and SWCNT surface in the 310 K trajec-
tory of the two REMD runs with SWCNT. The
data are averaged over the last 80 ns for random-
Ab(16-22)þSWCNT and the last 40 ns for sheet-
Ab(16-22)þSWCNT.
SWCNT Inhibits Ab16-22 b-Sheet Formation 2273carbon nanotubes (65), and recent atomic force microscopy
and optical absorption spectroscopy experiments indicating
that p-stacking interactions play an important role in
peptide-SWCNT interactions (66).
To investigate the detailed interactions between the
aromatic rings of Phe and SWCNT, we plot in Fig. 6 A
the PDF of the centroid distance (d) between the Phe ring
and its closest SWCNT carbon ring. There are three peaks
centered at 0.37, 0.5, and 0.75 nm, with a dominant peak
at 0.37 nm. To probe the favorable orientation between
the two rings around the three different distances, we calcu-
late the PDF of the interplanar ring angle at a centroid
distance of 0.3 % d % 0.45 nm (Fig. 6 B), 0.45 < d %
0.65 nm (Fig. 6 C), and d R 0.65 nm (Fig. 6 D). A peak
at 15 is observed in Fig. 6 B, indicating that the two rings
have a strong preference to be parallel-aligned when d <
0.45 nm. For 0.45 < d % 0.65 nm, the angle is mainly
distributed in the range of 60–90, with almost equal popu-
lation for each angle in this range, indicative of both perpen-
dicular (T-shaped) and staggered ring organizations. When
d > 0.65 nm, the PDF curve is almost flat for the angle in
the range of 30–90, with a rather broad peak around 50,
implying that the two rings can align in any orientation,
including parallel and T-shaped ones, with a slight prefer-
ence for a 50 orientation. These results suggest that there
are many possible stacking patterns between Phe aromatic
ring and SWCNT carbon ring, and the exact stacking orien-
tation depends on their centroid distance. In particular,
a parallel-aligned p-stacking geometry is likely to be the
most favorable one at a short distance. This is supportedC D
A B
0.45nm<d<0.65nm d>0.6
0.3nm<d
T-shaped 50
random-Aβ(16-22)+SWCNT
sheet-Aβ(16-22)+SWCNT
random-Aβ(16
sheet-Aβ(16-2
random-Aβ(16-22)+SWCNT
sheet-Aβ(16-22)+SWCNT
random-Aβ(16
sheet-Aβ(16-2by the PDF curve of the angle for the ring centroid distance
in the full distance range (Fig. S5), where a peak appears at
15. Of interest, the analysis of p-stacking in a group of
nonhomologous proteins with known x-ray crystal struc-
tures suggests a parallel-displaced p-stacking to be the
major organization of p-p interactions in proteins (67).
Finally, it is instructive to look at the role of water in all of
the REMD simulations. To that end, we calculated the
number of water molecules within 0.36 nm of every residue
at five different stages of the simulations (Fig. S6). Previous
experimental (68) and computational studies (44,64)
showed that the expulsion of interfacial water molecules is
a key event in the aggregation of amyloid peptides such
as Ab(16-22) (44,68). Consistent with those studies, fast
dehydration occurs in the early stage of Ab(16-22) oligo-
merization in solution without SWCNT (Fig. S6 A). The
number of contacting water molecules with the five HP
residues decreases within 2 ns and remains almost constant
after 5 ns. Remarkably, a rapid dehydration process is also
observed both in random-Ab(16-22)þSWCNT and sheet-
Ab(16-22)þSWCNT systems (Fig. S6, B and C), indicating
that the expulsion of water is an obligatory step in the inter-
actions of Ab(16-22) peptide with SWCNT. As shown in
Fig. S6 D, within the 70–110 ns time period, the hydration
status of the Ab(16-22) peptide with and without SWCNT
is quite similar, which implies that the water-peptide inter-
action is similar in magnitude among the three different
systems, and the significant decrease in b-sheet content of
Ab(16-22) aggregates in the presence of SWCNT results
from the SWCNT-peptide interactions.5nm
<0.45nm
Parallel
-22)+SWCNT
2)+SWCNT
-22)+SWCNT
2)+SWCNT
FIGURE 6 Analysis of p-stacking interactions
between the Phe aromatic ring and the SWCNT
carbon ring in random-Ab(16-22)þSWCNT and
sheet-Ab(16-22)þSWCNT systems at 310 K. (A)
The PDF of the centroid distance (d) between the
Phe ring (each Phe residue is considered) and its
closest SWCNT carbon ring. (B–D) The PDF of
the angle between the two rings with a centroid
distance of (B) 0.3 % d % 0.45 nm, (C) 0.45 <
d% 0.65 nm, and (D) dR 0.65 nm. The selection
of the three distances is based on the PDF peak in
panel A.
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2274 Li et al.CONCLUSIONS
In summary, based on three 110-ns all-atom REMD simula-
tions on Ab(16-22) octamers starting from two different
conformations in the absence and presence of SWCNT,
we propose the following inhibition mechanisms of
SWCNTonAb(16-22) nucleation (Fig. 7):Without SWCNT,
random Ab(16-22) chains form various b-sheet-rich oligo-
mers. The interaction of SWCNTwith amorphous aggregates
prevents b-sheet formation and leads to only disordered
coil aggregates at equilibrium. The interaction of SWCNT
with a prefibrillar b-sheet bilayer destabilizes the b-sheet
structure and induces the formation of disordered coil
aggregates.
An analysis of the probability distribution of the
minimum distance between the side chain of each residue
and the SWCNT surface provides evidence for strong
HP interactions between the CHC residues L17–A21 with
SWCNT, among which residues F19–F20 show the stron-
gest interactions with SWCNT through p-stacking interac-
tions. The interpeptide HP interactions and notably the
aromatic stacking interactions have been demonstrated to
be important for amyloid formation of several peptides,
including Ab(16-22) (34,69,70). However, certain experi-
mental observations show that mutations that replace the
aromatic side chains of F19 and F20 with leucines or isoleu-
cines promote aggregation of the Ab42 peptide, indicating
that aromatic p-stacking is not critical, at least for the
full-length Ab peptide (71). The strong HP and p-stacking
interactions between SWCNTand Ab(16-22) peptide would
interfere with the peptide-peptide interactions that are
responsible for Ab(16-22) aggregation, thus slowing down
the nucleation process. The SWCNT used in this study
has a diameter of 0.542 nm. It is expected that the increase
in the SWCNT diameter would change the Ab(16-22)
SWCNT interaction, thus affecting the inhibition extents
of SWCNT on Ab(16-22) aggregation. Further studies are
needed to understand the effect of SWNT diameter on
Ab(16-22) aggregation.+
+
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Biophysical Journal 101(9) 2267–2276The full-length Ab42 peptide contains one hydrophilic
patch spanning residues 1–15, and two HP regions spanning
residues 17–21 and 30–42 separated by a hydrophilic linker,
residues 22–29. Obviously, due to the hydrophilic character
of the N-terminal region and of the linker, these two regions
are not to be the most probable sites for Ab42-SWCNT
interactions. Region 30–42 with the amino acids A-I-I-G-
L-M-V-G-G-V-V-I-A is certainly another probable binding
site; however, this fragment is free of any aromatic residues.
On the basis of our simulations, we hypothesize that the HP
L17–A21 region is the most probable site for SWCNT inter-
actions, and the resulting propensity of residues 17–21 to
adopt random coil conformation upon binding to SWCNT
is likely to reduce the b-sheet formation of the same resi-
dues in the Ab40/42 oligomers, thereby prolonging the
lag time for Ab nucleation. Our hypothesis is supported
by a previous experimental study in which results from
a Thioflavin T fluorescence assay showed that fullerene
strongly inhibits Ab40 aggregation at the early stage by
specifically binding to the KLVFF motif (13). Overall, our
findings provide significant insight into the inhibition mech-
anism of HP nanoparticles (notably SWCNT) against the
aggregation of Ab(16-22) and full-length Ab, and provide
what to our knowledge are new clues for the development
of drug candidates against AD.SUPPORTING MATERIAL
Estimation of the integrated autocorrelation time of the potential energy,
description of the analysis parameters, calculation of the chain-independent
Ca-RMSD, and six figures are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(11)01177-5.
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